Epigenetic silencing of HTATIP2 in glioblastoma enhances nuclear translocation of the DNA-repair protein MPG affecting treatment resistance

Monika E. Hegi(University of Lausanne), Thi Tham Nguyen(University of Lausanne), Premnath Rajakannu(University of Lausanne), Minh Diêu Thanh Pham(University of Lausanne), Leo Weman(University of Lausanne), Alexander Jucht(University of Lausanne), Michelle C. Buri(University of Lausanne), Kristof Van Dommelen(University of Lausanne)
Research Square
November 15, 2022
10.21203/rs.3.rs-2266918/v1
Cited by 0Open Access
Full Text

Abstract

Related Papers

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp, Monika E. Hegi, Warren Mason et al.|The Lancet Oncology|2009|7.8k
WoLF PSORT: protein localization predictor
Paul Horton, Kyungjoon Park, Takeshi Obayashi et al.|Nucleic Acids Research|2007|4.2k
Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis
Pan Du, Xiao Zhang, Chiang‐Ching Huang et al.|BMC Bioinformatics|2010|2.3k
Functional normalization of 450k methylation array data improves replication in large cancer studies
Jean-Philippe Fortin, Aurélie Labbe, Mathieu Lemire et al.|Genome biology|2014|1k
Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma
Anastasia Murat, Eugenia Migliavacca, Thierry Gorlia et al.|Journal of Clinical Oncology|2008|734